Pulling SEC filings + quote and writing the call…

INTERPARFUMS INC
Next earnings Jul 21, 2026 · consensus $0.98 EPS, $342M rev
Last earnings +2.2% on 2026-05-05
Quality licensed-fragrance compounder at a fair price — durable brand portfolio, but growth has decelerated sharply and the model is structurally dependent on third-party licenses.
Revenue $1.49B · FY2025
Middling fundamentals and a rich price (~41% above fair value) leave little margin of safety — a wait-and-see.
Interparfums is a high-quality, capital-light operator in prestige fragrance with a diversified license portfolio (Jimmy Choo 17%, Coach 15%, Montblanc 15%, GUESS 12%, Lacoste 7%, DKNY 7%, Ferragamo 4%) distributed in 120+ countries. The fundamentals are clean: 63.6% gross margin, 18.2% operating margin, 19.1% ROE, and operating cash flow of $215M comfortably covering $24.4M of capex and $103M of dividends. The balance sheet is sound with $881M of equity against $176M of total debt, and retained earnings grew 8.6% to $829M. This is the profile of a steady compounder, and at 19.7x earnings and 2.2x sales, the market is paying a reasonable — not cheap — multiple for it.
The problem is deceleration. After three years of 20%+ revenue growth (FY22 +24%, FY23 +21%, FY24 +9.7%), FY25 grew just 2.5% on the top line and 2.5% on net income, while operating income actually declined 1.6%. Capex jumped 415% to $24.4M — a meaningful step-up for an asset-light business that explicitly states it doesn't own manufacturing — suggesting either distribution-center investment or a structural cost shift that is starting to compress operating leverage. EPS growth of 2.3% on a 19.7x multiple leaves limited room for multiple expansion.
Is IPAR a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $880M | $1.09B | $1.32B | $1.45B | $1.49B |
| Gross profit | $557M | $694M | $839M | $927M | $947M |
| Operating income | $148M | $194M | $251M | $275M | $270M |
| Net income | $87.4M | $121M | $153M | $164M | $168M |
| Diluted EPS | $2.75 | $3.78 | $4.75 | $5.12 | $5.24 |
| Net margin | 9.9% | 11.1% | 11.6% | 11.3% | 11.3% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Change in certifying accountant disclosed; auditor transition adds short-term oversight risk.
Q1 2026 10-Q filed; details Q1 operations as growth moderates from prior years.
Q1 2026 10-Q filed; details Q1 operations as growth moderates from prior years.
Pre-announced Q1 2026 preliminary sales/financial update ahead of full earnings.
FY2025 10-K: rev $1.49B (+2.5%), op income -1.6%, equity +18%; growth sharply slowing.
NT 10-K: notified late filing of FY2025 annual report, raising near-term reporting concern.
FY2025 earnings released: revenue +2.5% to $1.49B, EPS $5.24, growth markedly decelerating.
Companion 8-K (likely dividend or guidance update) issued alongside prelim-sales release.
Companion 8-K (likely dividend or guidance update) issued alongside prelim-sales release.
Sources: SEC EDGAR (CIK 0000822663, latest 10-Q filed 2026-05-05) · EODHD · Proprietary analysis · as of 6/25/2026, 1:46:59 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:46 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-04-02 | MADAR JEAN CEO | Sell | 20.0K @ $91.02 | $1.82M |
| 2026-01-23 | HEILBRONN FRANCOIS Director | Exercise | 1.50K @ $62.18 | $93.3K |
| 2026-01-22 | Harrison Gilbert Director | Exercise | 1.50K @ $62.18 | $93.3K |
| 2026-01-22 | BENSOUSSAN TORRES ROBERT Director | Exercise | 1.50K @ $62.18 | $93.3K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median